These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 349657)

  • 21. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease.
    Bennett B
    Br J Haematol; 1973 Aug; 25(2):273-4. PubMed ID: 4580214
    [No Abstract]   [Full Text] [Related]  

  • 24. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.
    Holmberg L; Borge L; Nilsson IM
    Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of plasma fractions in the treatment of hemophilia and von Willebrand's disease.
    Rizza CR; Biggs R
    Prog Hematol; 1969; 6():181-200. PubMed ID: 4889322
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
    Guimbretére J
    Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 29. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemophilia, von Willebrand's disease, and related conditions: a spectrum of laboratory and clinical disorders.
    Edson JR
    Hum Pathol; 1970 Sep; 1(3):387-98. PubMed ID: 5315694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
    Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
    Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous inheritance and expression of classical haemophilia A and type IIA von Willebrand's disease.
    Beddall AC; Enayat SM; Williams CE; Short PE; Hill FG
    J Clin Pathol; 1984 Sep; 37(9):1035-9. PubMed ID: 6432854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis and treatment of Willebrand's disease].
    Meili EO; Straub PW; Frick PG
    Schweiz Med Wochenschr; 1969 Dec; 99(50):1805-10. PubMed ID: 5311783
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical application of the chromogenic assay of factor VIII in haemophilia A, and different variants of von Willebrand's disease.
    Lethagen S; Ostergaard H; Nilsson IM
    Scand J Haematol; 1986 Nov; 37(5):448-53. PubMed ID: 3101169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological studies of factor VIII in haemophilia and von Willebrand's disease.
    Gralnick HR; Coller BS; Marchesi SL
    Nat New Biol; 1973 Aug; 244(139):281-2. PubMed ID: 4199570
    [No Abstract]   [Full Text] [Related]  

  • 36. Frequency and clinical and transfusional significance of rheumatoid factor in patients with haemophilia and von Willebrand's disease.
    Celada A; Aguado MT; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Vox Sang; 1984; 47(4):271-5. PubMed ID: 6333107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease.
    Barrow EM; Graham JB
    Physiol Rev; 1974 Jan; 54(1):23-74. PubMed ID: 4594032
    [No Abstract]   [Full Text] [Related]  

  • 38. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence.
    Miller CH; Hilgartner MW; Harris MB; Bussel JB; Aledort LM
    Am J Med Genet; 1986 May; 24(1):83-94. PubMed ID: 3085499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Von Willebrand's disease in pregnancy.
    Noller KL; Bowie EJ; Kempers RD; Owen CA
    Obstet Gynecol; 1973 Jun; 41(6):865-72. PubMed ID: 4541087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.